文献速递慢病防控与筛查免疫规划

鼻用双DNA佐剂系统通过树突状细胞与B-1a B细胞相互作用诱导抗动脉粥样硬化IgM抗体

A nasal double DNA adjuvant system induces atheroprotective IgM antibodies via dendritic cell-B-1a B cell interactions.
PubMed 文献 · Vaccine · 2022-01-24

本研究在载脂蛋白E缺陷(ApoE KO)小鼠中,以磷酸胆碱偶联钥孔血蓝蛋白(PC-KLH)为抗原,评估鼻用双DNA佐剂系统(pFL与CpG ODN)诱导抗PC特异性IgM及抗动脉粥样硬化的效果与机制。结果显示,与单用PC-KLH相比,双DNA佐剂系统增强了血浆、腹腔液和鼻洗液中PC特异性IgM的诱导,并减少主动脉弓动脉粥样硬化形成;机制涉及CD11c+树突状细胞与B-1a B细胞相互作用。

要点

  • 鼻用双DNA佐剂系统增强PC特异性IgM诱导,抗体特异性结合PC分子。
  • 末次免疫12周后,双DNA佐剂系统减少ApoE KO小鼠主动脉弓动脉粥样硬化。
  • 机制涉及CD11c+树突状细胞增多及与B-1a B细胞相互作用。

核心结论

  • 鼻用双DNA佐剂系统联合PC-KLH通过树突状细胞与B-1a B细胞相互作用,在黏膜和系统淋巴组织中诱导T15样抗体,并抑制动脉粥样硬化进展。

研究设计与样本

  • 使用载脂蛋白E缺陷(ApoE KO)小鼠,以磷酸胆碱偶联钥孔血蓝蛋白(PC-KLH)为抗原,比较鼻用双DNA佐剂系统(pFL与CpG ODN)与单用PC-KLH的免疫效果及机制。

主要发现

  • 与单用PC-KLH组相比,PC-KLH联合pFL和CpG ODN鼻免疫组血浆、腹腔液和鼻洗液中PC特异性IgM诱导增强。
  • 这些抗体对PC分子具有高度特异性结合,并与抗T15独特型(AB1-2)呈剂量依赖性结合。
  • 末次免疫12周后,PC-KLH联合双DNA佐剂系统组ApoE KO小鼠主动脉弓动脉粥样硬化形成减少。
  • PC-KLH联合双DNA佐剂系统组脾脏、腹腔(PEC)和鼻咽相关淋巴组织(NALT)中CD11c+树突状细胞频率显著增加,CD11c+树突状细胞表达增殖诱导配体和B细胞激活因子显著增加。
  • 双DNA佐剂系统组脾脏、PEC和NALT中B-1 B细胞数量显著增加,CD5+ B220+(B-1a)B细胞上跨膜激活剂和钙调节亲环素配体相互作用分子表达增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We previously demonstrated that the dendritic cell (DC)-targeting nasal double DNA adjuvant system, which consists of a DNA plasmid expressing Flt3 ligand (pFL) and CpG oligodeoxynucleotide 1826 (CpG ODN), elicits specific immune responses to various antigens in the mucosal and systemic compartments. Here, we investigated, using phosphorylcholine (PC)-conjugated keyhole limpet hemocyanin (PC-KLH) as an antigen, whether the nasal double DNA adjuvant system induces protective immunity to atherosclerosis in apolipoprotein E-deficient (ApoE KO) mice. Further, we assessed the molecular and cellular mechanisms in the induction of anti-PC-specific immune responses. Nasal immunization with PC-KLH plus pFL and CpG ODN enhanced induction of PC-specific IgM in plasma, peritoneal fluids, and nasal washes when compared with mice administered PC-KLH alone. Of importance, these antibodies exhibited highly specific binding to the PC molecule, and dose-dependent binding to anti-T15 idiotype (AB1-2). Twelve weeks after the last immunization, the nasal double DNA adjuvant system with PC-KLH resulted in a reduction of atherogenesis in the aortic arch of ApoE KO mice. Therefore, we next assessed immunocytological mechanism to induce these antibodies. The nasal double DNA adjuvant system with PC-KLH resulted not only in significantly increased frequencies of CD11c+ DCs in the spleen, peritoneal cavity (PEC), and nasopharyngeal-associated lymphoid tissues (NALT), but also significantly increased expression of a proliferation-inducing ligand and B-cell-activating factor by CD11c+ DCs. In addition, the double DNA adjuvant system induced significantly increased numbers of B-1 B cells in the spleen, PEC, and NALT, and increased expression of transmembrane activator and calcium modulator and cyclophilin ligand interactor on CD5+ B220+ (B-1a) B cells. These findings demonstrated that the nasal double DNA adjuvant system with PC-KLH resulted in the induction of T15-like antibodies in the mucosal and systemic lymphoid tissues through interaction between DCs and B-1a B cells, and inhibited the progression of atherogenesis.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yoshimatsu H, Kataoka K, Fujihashi K, et al. A nasal double DNA adjuvant system induces atheroprotective IgM antibodies via dendritic cell-B-1a B cell interactions. Vaccine. 2022. PMID: 35086743. doi:10.1016/j.vaccine.2022.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。